Amyris

Amyris is a biotechnology company that specializes in the development and production of sustainable ingredients for the health and wellness, flavors and fragrances, and cosmetics industries. The company was founded in 2003 and is headquartered in Emeryville, California, United States. Amyris uses synthetic biology and fermentation processes to create high-value, plant-based compounds that are traditionally derived from petrochemicals or plants.

The company's technology platform, known as the "Amyris Platform," enables the design, production, and optimization of microbial strains that can produce a wide range of target molecules. These molecules are then used to create ingredients that are more sustainable, cost-effective, and often have superior performance characteristics compared to their traditional counterparts. Amyris's portfolio includes ingredients such as squalane, farnesene, and valencene, which are used in various applications, including skincare, haircare, and perfumery.

Amyris has established partnerships with several major companies in the cosmetics and fragrance industries, including L'Oréal, Shiseido, and Givaudan, to develop and commercialize its ingredients. The company also operates a manufacturing facility in Brazil, where it produces some of its key ingredients.

In addition to its commercial activities, Amyris is involved in research and development efforts aimed at expanding its technology platform and discovering new applications for its ingredients. The company has received numerous awards and recognitions for its innovative approach to sustainable chemistry and its contributions to the bioeconomy. Amyris is listed on the New York Stock Exchange under the ticker symbol AMRS.